Skip to content

Clinical trials

Phase 4 Cardiovascular Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Phase 4 Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20032
20041
20081
20101
20111
20133
20141
20151

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kirby Institute3
Bayside Health2
Pfizer2
AstraZeneca1
Baker Heart and Diabetes Institute1
Boehringer Ingelheim1
Eisai Inc.1
Monash University1
St Vincent's Hospital, Sydney1
The George Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases15
HIV Infections3
Lipodystrophy3
Stroke3
Diabetes Mellitus2
Myocardial Infarction2
Obesity2
Acute Coronary Syndrome1
Anemia1
Arterial Occlusive Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.